LUMO: Nilai perusahaan marang bathi resik Lumos Pharma Corp

Simbol lan logo merek Lumos Pharma Inc (LUMO)

Lumos Pharma, Inc. (LUMO) prospects are tied to the results of trials for growth hormone deficiency treatments, while cash reserves help mitigate risks. The company is developing oral stimulants, replacing painful injections with the convenience of tablets. The share price history with the -1.10 indicator clearly demonstrates the asset's dynamics. The business relies on lifelong therapy for children with rare pathologies, ensuring a stable, multi-year cash inflow.

Pangali P/E: Lumos Pharma Corp (LUMO) kanggo 04.07.2022 - 21.12.2024

Rincian metrik komprehensif lan analitis Lumos Therapeutics (LUMO)

- rega lan prakiraan konsensus rega:
Ringkesan analisis perusahaan:Lumos Pharma Inc
Produk dadi Lumos Pharma Corp

Molecule screening automation at Lumos Pharma, Inc. (LUMO) accelerates drug discovery, impacting future profitability. The P/E ratio reflects this efficiency by dividing the market value of the share by the net profit from the previous year. This metric determines the theoretical payback period for investments via operating income. However, ignoring debt obligations distorts the real value of assets. By analyzing the P/E fluctuations of Lumos Pharma, Inc. (LUMO), an investor assesses the extent of the premium paid for technological potential.

Analisis perusahaan pesaing

Pangali P/E Ascendis Pharma Inc.|Koefisien rega marang bathi MDGL (Madrigal Pharma)|CORT (Corcept Therapeutics Corp) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi rhythmtx.com RYTM|AKRO - Koefisien rega marang bathi|Metsera Therapeutics - Pangali P/E|Kapitalisasi marang bathi MoonLake Pharma|CRNX (Crinetics) - Koefisien rega marang bathi|NAMS: Rasio rega pasar marang bathi resik|SLNO (Soleno Therapeutics Corp) - Pangali P/E|Pangali P/E Amicus Therapeutics|Pangali P/E ETNB|Rasio rega marang bathi AGIO (Agios)|Rasio rega marang bathi structuretx.com GPCR|MiMedx Corp (MDXG) - Kapitalisasi marang bathi|RZLT - Rasio rega marang bathi|LXRX: Rasio rega marang bathi|MBX Biosciences, Inc. (MBX) - Rasio rega marang bathi|ALT - Periode bali modal bisnis|Rasio rega marang bathi Aardvark Pharma|Sagimet Biosciences Inc (SGMT) - Periode bali modal bisnis|Rasio rega marang bathi bioagelabs.com (BIOA)|Koefisien rega marang bathi Biomea Fusion, Inc. BMEA|Rasio rega marang bathi Quince QNCX|GUTS (Fractyl Health Inc.) - Kapitalisasi marang bathi resik|VTVT: Koefisien rega marang bathi|Rasio kapitalisasi marang bathi resik agapeatpgroup.com (ATPC)|PLUR (Pluri) - Koefisien rega marang bathi|Pangali rega marang bathi SYBX|Rasio rega marang bathi Lipocine Corporation|matinasbiopharma.com (MTNB) - Periode bali modal bisnis|Pangali P/E SPRB|Koefisien rega marang bathi Galecto, Inc. GLTO|Rasio rega marang bathi Carmell Corporation CTCX|Organovo (ONVO) - Kapitalisasi marang bathi|RDUS: Koefisien rega marang bathi